La Jolla Profile

Performance

   

Odds of Distress

79%79%
Check how we calculate scores
Equity ratings for La Jolla Pharmaceutical Company are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 25, 2019 and ending today August 24, 2019. Click here to learn more.
10.31
USD 0.05  0.48%

La Jolla Summary

La Jolla Pharmaceutical Company (LJPC) is traded on BATS Exchange in USA. It is located in 4550 Towne Centre Court and employs 169 people. La Jolla is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 250.66M. La Jolla Pharmaceutical conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 27.08M outstanding shares of which 6.14M shares are now shorted by private and institutional investors with about 11.09 trading days to cover. LA JOLLA PHARMA currently holds about 123.45M in cash with (118.15M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.55.
Check La Jolla Probability Of Bankruptcy

Ownership Allocation (%)

La Jolla Target Price Odds Analysis

Odds Below 10.31HorizonTargetOdds Above 10.31
97.20%30 days 10.31 2.77%
Based on normal probability distribution, the odds of La Jolla to move above current price in 30 days from now is roughly 2.77% (This La Jolla Pharmaceutical Company probability density function shows the probability of La Jolla Stock to fall within a particular range of prices over 30 days) .

La Jolla Pharmaceutical Top Holders

La Jolla Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Tang Capital Management LlcCommon Shares4.9 M45.7 M
Fmr LlcCommon Shares4.1 M37.6 M
View La Jolla Diagnostics

La Jolla Pharmaceutical Company Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

La Jolla Key Fundamentals

La Jolla Against Markets

La Jolla Vital Trading Data

La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company was founded in 1989 and is headquartered in San Diego, California. La Jolla operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 169 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
La Jolla Pharmaceutical SEC Filings
La Jolla SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameLa Jolla Pharmaceutical Company
CEOGeorge TidmarshView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
RegionNorth America
LocationCalifornia U.S.A
Business Address4550 Towne Centre Court
ExchangeBATS Exchange
CIK Number0000920465
CUSIP503459505
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitelajollapharmaceutical.com
Phone858 207 4264
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJuly 15, 2019

La Jolla Corporate Directors

Chester Zygmont Director of Finance
Craig Johnson Independent Director
Robert Rosen Director
Please see also Stocks Correlation. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Search macroaxis.com